4.7 Review

Radiation-induced Adaptive Response: New Potential for Cancer Treatment

期刊

CLINICAL CANCER RESEARCH
卷 26, 期 22, 页码 5781-5790

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-20-0572

关键词

-

类别

资金

  1. NIH Intramural Research Program, NCI
  2. Center for Cancer Research [ZIA BC 010670]
  3. NATIONAL CANCER INSTITUTE [ZIABC010670, ZIABC010946, ZIASC006321] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Radiotherapy is highly effective due to its ability to physically focus the treatment to target the tumor while sparing normal tissue and its ability to be combined with systemic therapy. This systemic therapy can be utilized before radiotherapy as an adjuvant or induction treatment, during radiotherapy as a radiation sensitizer, or following radiotherapy as a part of combined modality therapy. As part of a unique concept of using radiation as focused biology, we investigated how tumors and normal tissues adapt to clinically relevant multifraction (MF) and single-dose (SD) radiation to observe whether the adaptations can induce susceptibility to cell killing by available drugs or by immune enhancement. We identified an adaptation occurring after MF (3 x 2 G gamma) that induced cell killing when AKT-mTOR inhibitors were delivered following cessation of radiotherapy. In addition, we identified inducible changes in integrin expression 2 months following cessation of radiotherapy that differ between MF (1 G gamma x 10) and SD (10 G gamma) that remain targetable compared with preradiotherapy. Adaptation is reflected across different omics studies, and thus the range of possible molecular targets is not only broad but also time, dose, and schedule dependent. While much remains to be studied about the radiation adaptive response, radiation should be characterized by its molecular perturbations in addition to physical dose. Consideration of the adaptive effects should result in the design of a tailored radiotherapy treatment plan that accounts for specific molecular changes to be targeted as part of precision multimodality cancer treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据